Cart
sales@molnova.com
(S)-ErSO
CAS No. 2407860-34-6
(S)-ErSO( —— )
Catalog No. M28246 CAS No. 2407860-34-6
(S)-ErSO is an inactive dextrorotatory enantiomer of ErSO.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 295 | Get Quote |
|
| 10MG | 507 | Get Quote |
|
| 25MG | 802 | Get Quote |
|
| 50MG | 1107 | Get Quote |
|
| 100MG | 1503 | Get Quote |
|
| 500MG | 3015 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(S)-ErSO
-
NoteResearch use only, not for human use.
-
Brief Description(S)-ErSO is an inactive dextrorotatory enantiomer of ErSO.
-
Description(S)-ErSO is an inactive dextrorotatory enantiomer of ErSO.(In Vitro):(S)-ErSO is inactive in MCF-7 cells while (R)-ErSO induces dose-dependent death.
-
In Vitro(-)-ErSO induces dose-dependent death of MCF-7 cells. (+)-l05 is inactive.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorEPAC1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2407860-34-6
-
Formula Weight453.33
-
Molecular FormulaC22H13F6NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 190 mg/mL (419.12 mM)
-
SMILESO=C1[C@](C=2C(N1)=C(C(F)(F)F)C=CC2)(C3=CC=C(OC(F)(F)F)C=C3)C4=CC=C(O)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Brown LM, et al. Allosteric inhibition of Epac: computational modeling and experimental validation to identify allosteric sites and inhibitors. J Biol Chem. 2014 Oct 17;289(42):29148-57.
molnova catalog
related products
-
trans-Isoferulic aci...
Isoferulic acid is an effective natural antioxidant in both lipid and aqueous media, it may be a new promising anti-glycation agent for the prevention of diabetic complications via inhibition of advanced glycation end products (AGEs) formation and oxidation-dependent protein damage.
-
AM-8123
AM-8123 is an orally available nonpeptide APJ agonist.AM-8123 reduces collagen load and improves cardiac function.
-
Crilvastatin
Crilvastatin (PMD 387) is a novel, non-competitive hydroxymethylglutaryl coenzyme A reductase inhibitor with cholesterol-lowering activity, inhibiting cholesterol uptake in rats with hereditary hypercholesterolemia.
